4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
GALDERMA GROUP N (GALD) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Zug, Switzerland with about 7,676 employees. Its market capitalization is roughly $40 billion. In the fiscal year ended 2025-12-31, GALD reported $5.2B in revenue and $613M in net income.
Galderma Group AG operates as a dermatology company worldwide. The company delivers a science-based portfolio of brands and services for the dermatology market, including injectable aesthetics, dermatological skincare, and therapeutic dermatology.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $5.2B | $4.4B | $4.1B | $3.8B | — |
| Gross Profit | $3.6B | $3.1B | $2.9B | $2.6B | — |
| Operating Income (EBIT) | $876M | $678M | $611M | $406M | — |
| Net Income | $613M | $231M | ($57M) | ($98M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Dividends Paid | ($41M) | — | — | — | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Total Assets | $13.4B | $12.6B | $12.5B |
| Total Liabilities | $5.2B | $4.8B | $7.1B |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive GALD viewer.
About TickerBase · Data methodology & sources · Privacy · Terms